PERMEABILITY OF THE BLOOD-BRAIN-BARRIER TO SOLUBLE CYTOKINE RECEPTORS

被引:76
作者
BANKS, WA [1 ]
PLOTKIN, SR [1 ]
KASTIN, AJ [1 ]
机构
[1] TULANE UNIV,SCH MED,NEW ORLEANS,LA 70112
关键词
INTERLEUKIN; TUMOR NECROSIS FACTOR-ALPHA; CENTRAL NERVOUS SYSTEM; TRANSPORT; BRAIN; ENDOTHELIUM; SATURABLE; MOUSE; HUMAN;
D O I
10.1159/000096887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Soluble receptors for cytokines can be important regulators of cytokine function. By binding to their cytokine ligands, they act as antagonists and carrier proteins. We investigated whether the blood-to-brain saturable transport of human tumor necrosis factor-alpha (TNF) and human interleukin-1 alpha (IL-1) radioactively labeled with I-125 could be blocked by preincubation with their soluble receptors. At ratios of 100:1 and 1,000: 1 of receptor to cytokine, the soluble p75 human receptor to TNF (rhuTNFR:Fc) totally blocked the entry of human or murine TNF into the brain. However, the soluble murine receptor to IL-1 (muIL-1R) only partially blocked IL-1 entry. Radioactively labeled rhuTNFR:Fc and muIL-1R were not transported across the blood-brain barrier (BBB) and were no more able to penetrate the BBB than the vascular marker serum albumin. This indicates that the transporter at the BBB for IL-1, but not the one for TNF, can strip the cytokine from its soluble receptor. These findings might be useful in determining which, if any, of the actions exerted on the brain by blood-borne cytokines are due to penetration of the BBB.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 50 条
[21]   Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications [J].
Gao, Zhen ;
Chen, Yang ;
Cai, Xiaoshu ;
Xu, Rong .
BIOINFORMATICS, 2017, 33 (06) :901-908
[22]   Permeability of the Blood-Brain Barrier to a Rhenacarborane [J].
Hawkins, Patrick M. ;
Jelliss, Paul A. ;
Nonaka, Naoko ;
Shi, Xiaoming ;
Banks, William A. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (02) :608-614
[23]   Permeability of the blood-brain barrier to neurotrophins [J].
Pan, WH ;
Banks, WA ;
Kastin, AJ .
BRAIN RESEARCH, 1998, 788 (1-2) :87-94
[24]   A MORPHOMETRIC STUDY OF THE BLOOD-BRAIN-BARRIER IN ALZHEIMERS-DISEASE [J].
STEWART, PA ;
HAYAKAWA, K ;
AKERS, MA ;
VINTERS, HV .
LABORATORY INVESTIGATION, 1992, 67 (06) :734-742
[25]   Physiological and pathological consequences of exosomes at the blood-brain-barrier interface [J].
Salimi, Leila ;
Seyedaghamiri, Fatemehsadat ;
Karimipour, Mohammad ;
Mobarak, Halimeh ;
Mardi, Narges ;
Taghavi, Maryam ;
Rahbarghazi, Reza .
CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)
[26]   KINETICS OF ARGININE-VASOPRESSIN UPTAKE AT THE BLOOD-BRAIN-BARRIER [J].
ZLOKOVIC, BV ;
HYMAN, S ;
MCCOMB, JG ;
LIPOVAC, MN ;
TANG, G ;
DAVSON, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1025 (02) :191-198
[27]   MANGANESE NEUROTOXICITY - CELLULAR EFFECTS AND BLOOD-BRAIN-BARRIER TRANSPORT [J].
ASCHNER, M ;
ASCHNER, JL .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1991, 15 (03) :333-340
[28]   INVIVO APPROACHES FOR STUDYING PEPTIDE INTERACTIONS AT THE BLOOD-BRAIN-BARRIER [J].
ZLOKOVIC, BV .
JOURNAL OF CONTROLLED RELEASE, 1990, 13 (2-3) :185-201
[29]   OSMOTIC BLOOD-BRAIN-BARRIER DISRUPTION - CT AND RADIONUCLIDE IMAGING [J].
ROMANGOLDSTEIN, S ;
CLUNIE, DA ;
STEVENS, J ;
HOGAN, R ;
MONARD, J ;
RAMSEY, F ;
NEUWELT, EA .
AMERICAN JOURNAL OF NEURORADIOLOGY, 1994, 15 (03) :581-590
[30]   RECEPTOR-MEDIATED ENDOCYTOSIS OF TRANSFERRIN AT THE BLOOD-BRAIN-BARRIER [J].
ROBERTS, RL ;
FINE, RE ;
SANDRA, A .
JOURNAL OF CELL SCIENCE, 1993, 104 :521-532